Crinetics Pharmaceuticals CRNX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$127.85M-4.1% | -$122.82M+5.6% | -$130.09M-12.5% | -$115.64M-19.5% | -$96.77M-20.1% | ||
| $1.16M+16.7% | $994K-1.8% | $1.01M+5.5% | $959K+3.7% | $925K+17.4% | ||
| $29.68M+36.6% | $21.72M-4.3% | $22.7M-13.1% | $26.12M+27.6% | $20.48M+8.7% | ||
| -$124.7M-34.2% | -$92.9M+16.1% | -$110.72M-29.0% | -$85.85M+2.9% | -$88.45M-32.3% | ||
| $820K+79.0% | $458K-46.9% | $863K-73.0% | $3.2M+158% | $1.24M+20.4% | ||
| -$252.36M-542% | $57.11M-65.3% | $164.81M+334% | $37.95M+144% | -$85.96M+84.1% | ||
| $389.88M+1,398% | $26.04M+744% | $3.08M-56.3% | $7.06M+59.0% | $4.44M-99.2% | ||
| $12.81M+231% | -$9.76M— | —— | -$40.84M+76.0% | -$169.98M— | ||
| -$125.52M-34.5% | -$93.36M+16.3% | -$111.58M-25.3% | -$89.05M+0.7% | -$89.69M-32.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Crinetics Pharmaceuticals's cash flow data come from?
- Every line is extracted from Crinetics Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.